For this purpose, we first assessed the levels of MYC and MiT/TFE proteins in a human tumor tissue microarray derived from colon adenocarcinoma, and in patient-derived xenografts from group 3 medulloblastoma and rhabdomyosarcoma. The gene discussed is MYC; the disease is colon adenocarcinoma.